Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
39 hedge funds and large institutions have $85.8M invested in Tetraphase Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 13 closing their positions.
51% more capital invested
Capital invested by funds: $56.8M → $85.8M (+$29M)
40% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 10
5% less funds holding
Funds holding: 41 → 39 (-2)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$3.19M |
| 2 |
HCM
Harvey Capital Management
Palm Beach,
Florida
|
+$1.31M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.12M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$924K |
| 5 |
State Street
Boston,
Massachusetts
|
+$428K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.9M |
| 2 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
-$2.58M |
| 3 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$2.2M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$780K |
| 5 |
Morgan Stanley
New York
|
-$570K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Citigroup
New York
| – | -$17.3K | -99 | -99% |
|
52
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$5K | -33 | Closed |
|
TTPH Hedge Fund Activity: Q3 2013 in Review
39 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q3 2013, worth a combined $85.8M — up 51% from $56.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of TTPH and 11 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 14 added.
The largest buyer was Broadfin Capital, adding an estimated $3.19M. The largest seller was Deerfield Management, exiting entirely with an estimated $3.9M sold.
- 39 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q3 2013, down from 41 in Q2 2013.
- Funds reported $85.8M of Tetraphase Pharmaceuticals, Inc. stock for Q3 2013, up 51% quarter-over-quarter.
- 11 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q3 2013 and 13 closed out, a net change of -2 holders.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q3 2013 was Broadfin Capital, an estimated $3.19M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q3 2013 was Deerfield Management, an estimated $3.9M sold.
Based on aggregated 13F filings for Q3 2013.